These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 18501722)

  • 1. Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes.
    Wanninger J; Neumeier M; Weigert J; Liebisch G; Weiss TS; Schäffler A; Aslanidis C; Schmitz G; Schölmerich J; Buechler C
    Biochim Biophys Acta; 2008; 1781(6-7):321-5. PubMed ID: 18501722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes.
    Neumeier M; Sigruener A; Eggenhofer E; Weigert J; Weiss TS; Schaeffler A; Schlitt HJ; Aslanidis C; Piso P; Langmann T; Schmitz G; Schölmerich J; Buechler C
    Biochem Biophys Res Commun; 2007 Jan; 352(2):543-8. PubMed ID: 17129575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octanoate reduces very low-density lipoprotein secretion by decreasing the synthesis of apolipoprotein B in primary cultures of chicken hepatocytes.
    Tachibana S; Sato K; Cho Y; Chiba T; Schneider WJ; Akiba Y
    Biochim Biophys Acta; 2005 Oct; 1737(1):36-43. PubMed ID: 16226916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver.
    Sjöberg A; Oscarsson J; Boström K; Innerarity TL; Edén S; Olofsson SO
    Endocrinology; 1992 Jun; 130(6):3356-64. PubMed ID: 1597147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of ORMDL3 single nucleotide polymorphisms with lysophosphatidylcholine and apolipoprotein B levels in children with asthma].
    Wang BJ; Wang GL; Chen DH; Wang WX; Huang J; Rong JY; Liu XT; Yang S
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):241-4. PubMed ID: 25815492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency.
    Jiang XC; Qin S; Qiao C; Kawano K; Lin M; Skold A; Xiao X; Tall AR
    Nat Med; 2001 Jul; 7(7):847-52. PubMed ID: 11433351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of hepatic expression and secretion of selenoprotein P by metformin.
    Speckmann B; Sies H; Steinbrenner H
    Biochem Biophys Res Commun; 2009 Sep; 387(1):158-63. PubMed ID: 19576170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids.
    Bartolomé N; Rodríguez L; Martínez MJ; Ochoa B; Chico Y
    Ann N Y Acad Sci; 2007 Jan; 1096():55-69. PubMed ID: 17405916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
    Chong T; Naples M; Federico L; Taylor D; Smith GJ; Cheung RC; Adeli K
    Atherosclerosis; 2006 Mar; 185(1):21-31. PubMed ID: 16002078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes.
    Sogame Y; Kitamura A; Yabuki M; Komuro S
    Biopharm Drug Dispos; 2009 Nov; 30(8):476-84. PubMed ID: 19768675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers for glycaemic deterioration in type 2 diabetes.
    Slieker RC; Donnelly LA; Akalestou E; Lopez-Noriega L; Melhem R; Güneş A; Abou Azar F; Efanov A; Georgiadou E; Muniangi-Muhitu H; Sheikh M; Giordano GN; Åkerlund M; Ahlqvist E; Ali A; Banasik K; Brunak S; Barovic M; Bouland GA; Burdet F; Canouil M; Dragan I; Elders PJM; Fernandez C; Festa A; Fitipaldi H; Froguel P; Gudmundsdottir V; Gudnason V; Gerl MJ; van der Heijden AA; Jennings LL; Hansen MK; Kim M; Leclerc I; Klose C; Kuznetsov D; Mansour Aly D; Mehl F; Marek D; Melander O; Niknejad A; Ottosson F; Pavo I; Duffin K; Syed SK; Shaw JL; Cabrera O; Pullen TJ; Simons K; Solimena M; Suvitaival T; Wretlind A; Rossing P; Lyssenko V; Legido Quigley C; Groop L; Thorens B; Franks PW; Lim GE; Estall J; Ibberson M; Beulens JWJ; 't Hart LM; Pearson ER; Rutter GA
    Nat Commun; 2023 May; 14(1):2533. PubMed ID: 37137910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of the Effect of Metformin and Insulin on Gut Microbiota and Metabolome Profiles of Type 2 Diabetic Rats Induced by the Combination of Streptozotocin and High-Fat Diet.
    Hu N; Zhang Q; Wang H; Yang X; Jiang Y; Chen R; Wang L
    Front Pharmacol; 2021; 12():794103. PubMed ID: 35046817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.
    Tseng CH
    Front Oncol; 2020; 10():587666. PubMed ID: 33194743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent and Opposite Associations Between Branched-Chain Amino Acids and Lysophosphatidylcholines With Incident Diabetes in Thais.
    Chailurkit LO; Paiyabhroma N; Sritara P; Vathesatogkit P; Yamwong S; Thonmung N; Ongphiphadhanakul B
    Metabolites; 2020 Feb; 10(2):. PubMed ID: 32093149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.
    Garzel B; Hu T; Li L; Lu Y; Heyward S; Polli J; Zhang L; Huang SM; Raufman JP; Wang H
    Pharm Res; 2020 Jan; 37(2):26. PubMed ID: 31907698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.
    Bornstein S; Moschetta M; Kawano Y; Sacco A; Huynh D; Brooks D; Manier S; Fairfield H; Falank C; Roccaro AM; Nagano K; Baron R; Bouxein M; Vary C; Ghobrial IM; Rosen CJ; Reagan MR
    Endocrinology; 2017 Oct; 158(10):3369-3385. PubMed ID: 28977604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function.
    Hollie NI; Cash JG; Matlib MA; Wortman M; Basford JE; Abplanalp W; Hui DY
    Biochim Biophys Acta; 2014 Jun; 1841(6):888-95. PubMed ID: 24315825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.